We hypothesized that the presence of APOE and BDNF risk genetic polymorphisms would be associated with more severe MBI symptoms in aMCI due to AD individuals compared to non-carriers of these polymorphisms and that the interaction between APOE and/or BDNF polymorphisms would be significantly associated with MBI-C severity. This evidence concerns the gene APOE and Alzheimer disease.